These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29284499)

  • 41. Quantification of left atrial strain and strain rate using Cardiovascular Magnetic Resonance myocardial feature tracking: a feasibility study.
    Kowallick JT; Kutty S; Edelmann F; Chiribiri A; Villa A; Steinmetz M; Sohns JM; Staab W; Bettencourt N; Unterberg-Buchwald C; Hasenfuß G; Lotz J; Schuster A
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):60. PubMed ID: 25196447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy.
    Nedios S; Dinov B; Seewöster T; Lindemann F; Richter S; Arya A; Dagres N; Husser D; Bollmann A; Hindricks G; Müssigbrodt A
    Sci Rep; 2021 Jun; 11(1):12411. PubMed ID: 34127728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atrial Mechanics in Hypertrophic Cardiomyopathy: Discriminating between Ventricular Hypertrophy and Fibrosis.
    Marques-Alves P; Ferreira JA; Freitas AA; Almeida JP; Baptista R; Castro G; Martins R; Donato P; Ferreira MJ; Gonçalves L
    Arq Bras Cardiol; 2022 Jan; 118(1):77-87. PubMed ID: 35195213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers.
    Negri F; Sanna GD; Di Giovanna G; Cittar M; Grilli G; De Luca A; Dal Ferro M; Baracchini N; Burelli M; Paldino A; Del Franco A; Pradella S; Todiere G; Olivotto I; Imazio M; Sinagra G; Merlo M
    Circ Cardiovasc Imaging; 2024 Apr; 17(4):e016042. PubMed ID: 38563190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Chung H; Kim Y; Park CH; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):18. PubMed ID: 33658040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Difference in left atrial myocardial dynamics during reservoir phase between hypertrophic cardiomyopathy and hypertensive heart determined using three-dimensional speckle tracking echocardiography.
    Yanagi Y; Okada K; Kaga S; Mikami T; Aiba M; Masauzi N; Murayama M; Tanemura A; Yokoyama S; Nishino H; Nakabachi M; Tamaki Y; Aoyagi H; Motoi K; Ishizaka S; Chiba Y; Tsujinaga S; Iwano H; Anzai T
    Int J Cardiovasc Imaging; 2022 Aug; 38(8):1781-1791. PubMed ID: 37726515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
    Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
    Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of fast semi-automated left atrial long-axis strain analysis in hypertrophic cardiomyopathy.
    Yang F; Wang L; Wang J; Pu L; Xu Y; Li W; Wan K; Yang D; Sun J; Han Y; Zhu Y; Chen Y
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):36. PubMed ID: 33761947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study.
    Zhou D; Yang W; Yang Y; Yin G; Li S; Zhuang B; Xu J; He J; Wu W; Jiang Y; Sun X; Wang Y; Sirajuddin A; Zhao S; Lu M
    BMC Cardiovasc Disord; 2022 Mar; 22(1):99. PubMed ID: 35282817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
    Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
    J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.
    Lakdawala NK; Thune JJ; Maron BJ; Cirino AL; Havndrup O; Bundgaard H; Christiansen M; Carlsen CM; Dorval JF; Kwong RY; Colan SD; Køber LV; Ho CY
    Am J Cardiol; 2011 Dec; 108(11):1606-13. PubMed ID: 21943931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypertrophic cardiomyopathy in myosin-binding protein C (
    Adalsteinsdottir B; Burke M; Maron BJ; Danielsen R; Lopez B; Diez J; Jarolim P; Seidman J; Seidman CE; Ho CY; Gunnarsson GT
    Open Heart; 2020; 7(1):e001220. PubMed ID: 32341788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.
    Tian H; Cui J; Yang C; Hu F; Yuan J; Liu S; Yang W; Jiang X; Qiao S
    BMC Cardiovasc Disord; 2018 Nov; 18(1):207. PubMed ID: 30390664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biatrial performance in children with hypertrophic cardiomyopathy: CMR study.
    Mazurkiewicz Ł; Ziółkowska L; Petryka J; Śpiewak M; Małek Ł; Kubik A; Marczak M; Misko J; Brzezińska-Rajszys G
    Eur Radiol; 2018 Dec; 28(12):5148-5159. PubMed ID: 29882072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left atrial function and phenotypes in asymmetric hypertrophic cardiomyopathy.
    Kobayashi Y; Wheeler M; Finocchiaro G; Ariyama M; Kobayashi Y; Perez MV; Liang D; Kuznetsova T; Schnittger I; Ashley E; Haddad F
    Echocardiography; 2017 Jun; 34(6):843-850. PubMed ID: 28370331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.